March, 2004
No. 89 (3)

Articles

Survival of elderly patients with acute myeloid leukemia

A Pulsoni, L Pagano, R Latagliata, M Casini, R Cerri, M Crugnola, L De Paoli, E Di Bona, R Invernizzi, F Marmont, MC Petti, G Rigolin, F Ronco, A Spadano, ME Tosti, G Visani, A Mele, F Mandelli

https://doi.org/10.3324/%25x

Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine

PL Zinzani, M Tani, E Marchi, V Stefoni, L Alinari, G Musuraca, A Gabriele, S Pileri, M Baccarani

https://doi.org/10.3324/%25x

Guidelines

Letters to the Editor

Submicroscopic deletions in 5q- associated malignancies

B Crescenzi, R La Starza, S Romoli, D Beacci, C Matteucci, G Barba, A Aventin, P Marynen, S Ciolli, C Nozzoli, MF Martelli, C Mecucci

https://doi.org/10.3324/%25x

Case Reports

Splenectomy in relapsing and plasma-refractory acquired thrombotic thrombocytopenic purpura

JA Kremer Hovinga, JD Studt, F Demarmels Biasiutti, M Solenthaler, L Alberio, C Zwicky, S Fontana, BM Taleghani, A Tobler, B Laemmle

https://doi.org/10.3324/%25x

Homozygosity for transferrin receptor-2 Y250X mutation induces early iron overload

A Piperno, A Roetto, R Mariani, S Pelucchi, C Corengia, F Daraio, A Piga, G Garozzo, C Camaschella

https://doi.org/10.3324/%25x

Clinical Trial

The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes

I Del Giudice, E Matutes, R Morilla, A Morilla, K Owusu-Ankomah, F Rafiq, R A'Hern, J Delgado, MB Bazerbashi, D Catovsky

https://doi.org/10.3324/%25x

Clinical Trial, Phase II

Comments